About Eurofins Scientific
Eurofins Scientific (hereinafter at times "Eurofins" or "the Group"), through its auxiliaries, trusts it is a logical pioneer in food, climate, drug, and beautifying agents items testing and in agroscience CRO administrations. It is likewise one of the worldwide autonomous market pioneers in certain testing and research center administrations for genomics, revelation pharmacology, crime scene investigation, CDMO, progressed material sciences, and supporting clinical examinations. Likewise, Eurofins is one of the main worldwide arising major parts in forte clinical symptomatic testing. With around 45,000 staff in excess of 800 research facilities across 47 nations, Eurofins offers an arrangement of more than 200,000 logical techniques for assessing the security, personality, organization, credibility, birthplace, and virtue of natural substances and items, just as for creative clinical symptomatic. The Group's goal is to furnish its clients with top notch administrations, precise outcomes on schedule, and master counsel from exceptionally qualified staff.
Eurofins is focused on seeking after its dynamic development technique by extending its innovation portfolio and its geographic reach. Through R and D and acquisitions, the Group draws on the most recent advancements in biotechnology and insightful science to offer its customers extraordinary logical arrangements and the most complete scope of testing strategies.
As perhaps the most creative and quality-arranged worldwide parts in its industry, Eurofins is obviously situated to help its customers' undeniably severe quality and security principles and the growing requests of administrative specialists all throughout the planet.
The portions of Eurofins Scientific are recorded on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).